Media coverage
9
Media coverage
Title Onconova Therapeutics Announces Publication of Phase 1 Results in Leukemia Research Exploring Oral Rigosertib in Combination with Azacitidine in Higher-Risk MDS Nasdaq:ONTX Media name/outlet Global English (Middle East and North Africa Financial Network) Country/Territory Jordan Date 7/07/20 Persons Lewis Silverman Title Onconova Therapeutics Announces Publication of Phase 1 Results in Leukemia Research Exploring Oral Rigosertib in Combination with Azacitidine in Higher-Risk MDS Media name/outlet Morningstar.com Country/Territory United States Date 7/07/20 URL https://www.morningstar.com/news/globe-newswire/7955688/onconova-therapeutics-announces-publication-of-phase-1-results-in-leukemia-research-exploring-oral-rigosertib-in-combination-with-azacitidine-in-higher-risk-mds Persons Lewis Silverman Title Publication of Phase 1 Results in Leukemia Research Exploring Oral Rigosertib in Combination with Azacitidine in Higher Risk MDS Media name/outlet Market News Publishing Country/Territory United States Date 7/07/20 Persons Lewis Silverman Title Onconova Therapeutics Announces Publication of Phase 1 Results in Leukemia Research Exploring Oral Rigosertib in Combination with Azacitidine in Higher-Risk MDS Media name/outlet India Pharma News Country/Territory India Date 7/07/20 Persons Lewis Silverman Title Onconova Therapeutics Announces Publication of Phase 1 Results in Leukemia Research Exploring Oral Rigosertib in Combination with Azacitidine in Higher-Risk MDS Media name/outlet MarketScreener.com Country/Territory United States Date 7/07/20 URL https://www.marketscreener.com/ONCONOVA-THERAPEUTICS-IN-46372025/news/Onconova-Therapeutics-Announces-Publication-of-Phase-1-Results-in-Leukemia-Research-Exploring-Oral-R-30887128/ Persons Lewis Silverman Title Onconova Therapeutics Announces Publication of Phase 1 Results in Leukemia Research Exploring Oral Rigosertib in Combination with Azacitidine in Higher-Risk MDS Media name/outlet GlobeNewswire Country/Territory United States Date 7/07/20 URL www.globenewswire.com/news-release/2020/07/07/2058521/0/en/Onconova-Therapeutics-Announces-Publication-of-Phase-1-Results-in-Leukemia-Research-Exploring-Oral-Rigosertib-in-Combination-with-Azacitidine-in-Higher-Risk-MDS.html Persons Lewis Silverman Title Onconova Therapeutics Announces Publication of Phase 1 Results in Leukemia Research Exploring Oral Rigosertib in Combination with Azacitidine in Higher-Risk MDS Media name/outlet PrimeNewswire (Top News) Country/Territory United States Date 7/07/20 Persons Lewis Silverman Title Onconova Therapeutics Announces Publication of Phase 1 Results in Leukemia Research Exploring Oral Rigosertib in Combination with ... Media name/outlet EIN Presswire Country/Territory United States Date 7/07/20 URL https://www.einpresswire.com/article/521168384/onconova-therapeutics-announces-publication-of-phase-1-results-in-leukemia-research-exploring-oral-rigosertib-in-combination-with-azacitidine-in Persons Lewis Silverman Title Onconova Therapeutics Announces Publication of Phase 1 Results in Leukemia Research Exploring Oral Rigosertib in Combination with Azacitidine in Higher-Risk MDS Media name/outlet BizWire Express Country/Territory India Date 7/07/20 URL www.bizwireexpress.com/showstoryGNW.php?storyid=30033 Persons Lewis Silverman